<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002870'>Obstructive sleep apnea</z:hpo> (OSA)-induced biological changes include intermittent <z:mp ids='MP_0005039'>hypoxia</z:mp>, intermittent <z:mp ids='MP_0002318'>hypercapnia</z:mp>, intrathoracic pressure changes, sympathetic activation and sleep fragmentation </plain></SENT>
<SENT sid="1" pm="."><plain>OSA can cause metabolic dysregulation, <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e>, systemic <z:mp ids='MP_0001845'>inflammation</z:mp>, <z:mp ids='MP_0003674'>oxidative stress</z:mp> and hypercoagulation, and neurohumoral changes </plain></SENT>
<SENT sid="2" pm="."><plain>There is evidence suggesting that OSA is independently associated with <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>OSA has been shown to increase the risk for <z:hpo ids='HP_0000822'>systemic hypertension</z:hpo>, pulmonary <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e>, <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">ischemic heart disease</z:e>, cerebral <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e>, <z:hpo ids='HP_0001635'>congestive heart failure</z:hpo> and <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Although there are evidences accumulating that there may be a causal relationship between OSA and <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disorders</z:e>, there is a need for more data from randomized controlled intervention trials to confirm this relationship </plain></SENT>
<SENT sid="5" pm="."><plain>Many risk factors of OSA (age, male gender and <z:hpo ids='HP_0001513'>obesity</z:hpo>) are also known risk factors for <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Severe OSA-<z:mp ids='MP_0001956'>hypopnea</z:mp> significantly increases the risk of fatal and nonfatal cardiovascular events in both men and women, and continuous positive airway pressure treatment reduces this risk in both </plain></SENT>
<SENT sid="7" pm="."><plain>Neurocognitive consequences of OSA include daytime sleepiness, loss of alertness, <z:e sem="disease" ids="C0233794" disease_type="Mental or Behavioral Dysfunction" abbrv="">memory deficit</z:e>, reduced vigilance, impaired executive function, increased risk for automobile and occupational accidents, and decreased quality of life </plain></SENT>
</text></document>